From cel­list to syn­thet­ic cell-ist: Jef­frey Kim scores $23M to reimag­ine blood tests, cell ther­a­py

It wasn’t al­ways Jef­frey Kim’s am­bi­tion to launch a biotech. In fact, af­ter grad­u­at­ing with his bach­e­lor’s de­gree in mol­e­c­u­lar bi­ol­o­gy from Prince­ton Uni­ver­si­ty, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER